tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Chase Knickerbocker, 76 are a BUY (97.44%), 2 are a HOLD (2.56%).
Analyst Chase Knickerbocker, currently employed at CRAIG HALLUM, carries an average stock price target met ratio of 43.2% that have a potential upside of 52.4% achieved within 159 days.
Chase Knickerbocker’s has documented 153 price targets and ratings displayed on 18 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on MDXG, MiMedx Group at 27-Aug-2026.
Analyst best performing recommendations are on ETON (ETON PHARMACEUTICALS).
The best stock recommendation documented was for IRWD (IRONWOOD PHARMACEUTICALS) at 10/29/2025. The price target of $1.7 was fulfilled within 2 days with a profit of $0.19 (12.58%) receiving and performance score of 62.91.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 16-Dec-2022
$12
$8.63 (256.08%)
$12
2 years 11 days ago
(26-Sep-2024)
1/3 (33.33%)
$8.93 (290.88%)
3
Buy Since 26-Sep-2024
$8
$4.63 (137.39%)
2 years 11 days ago
(26-Sep-2024)
0/1 (0%)
$4.93 (160.59%)
Buy
$2.5
$-0.28 (-10.07%)
3 years 7 months 22 days ago
(15-Feb-2023)
1/1 (100%)
$1.86 (290.63%)
145
Buy Since 18-Jul-2019
$29.41
$26.04 (772.70%)
$30
4 years 3 months 15 days ago
(22-Jun-2022)
0/5 (0%)
$24 (443.62%)
Buy Since 09-Jul-2019
$12
$8.63 (256.08%)
$144
6 years 1 months 5 days ago
(02-Sep-2020)
1/2 (50%)
$1.58 (15.16%)
19
Which stock is Chase Knickerbocker most bullish on?
Which stock is Chase Knickerbocker most reserved on?
What Year was the first public recommendation made by Chase Knickerbocker?
